Immunocore Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Immunocore Holdings generated cash of $2,940,000, which is more than the previous year. Cash used in financing activities reached the amount of $34,346,000 last year. Net change in cash is therefore $40,154,000.
Cash Flow
| 2018 | -16.62M | 58.01M | 101K |
|---|---|---|---|
| 2019 | -101.37M | -4.13M | 55.12M |
| 2020 | -60.57M | 467K | 115.94M |
| 2021 | -129.74M | -495K | 276.25M |
| 2022 | -31.26M | 233K | 138.22M |
| 2023 | 2.94M | -5.42M | 34.34M |
IMCR Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 402.47M | 287.29M | 175.11M | 73.96M | 124.38M | 82.88M |
Operating activities | ||||||
Net income | -43.36M | -41.22M | -131.52M | -74.09M | -103.93M | -71.63M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 4.09M | 6.13M | 7.01M | 8.97M | 9.21M | 6.70M |
Stock-based compensation expense | 32.46M | 32.88M | 48.89M | 8.16M | 3.05M | 666K |
| Deferred income tax benefit | 32.46M | 32.88M | 48.89M | 8.16M | 3.05M | 666K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | -32.09M | -5.14M | -532K | 1.82M | 0 |
Inventories | 0 | -4.91M | -1.47M | 0 | 0 | 0 |
Accounts payable | 0 | 4.91M | 1.47M | 0 | 0 | 0 |
Cash generated by operating activities | 2.94M | -31.26M | -129.74M | -60.57M | -101.37M | -16.62M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -4.25M | -2.19M | -1.00M | -3.07M | -4.27M | -3.53M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -5.42M | 233K | -495K | 467K | -4.13M | 58.01M |
Financing activities | ||||||
Common Stock Issued | 0 | 139.51M | 226.52M | 83.21M | 59.87M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -3.15M | -4.42M | -4.03M | 0 |
Cash used in financing activities | 34.34M | 138.22M | 276.25M | 115.94M | 55.12M | 101K |
Net Change In Cash | 40.15M | 114.31M | 146.03M | 55.75M | -50.41M | 41.50M |
Cash at end of period | 442.62M | 401.60M | 321.14M | 129.71M | 73.96M | 124.38M |
| Data source | Data source | Data source | Data source |